↓ Skip to main content

CD30: an important new target in hematologic malignancies

Overview of attention for article published in Leukemia & Lymphoma, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
patent
4 patents

Readers on

mendeley
37 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
CD30: an important new target in hematologic malignancies
Published in
Leukemia & Lymphoma, May 2011
DOI 10.3109/10428194.2011.574761
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United Kingdom 1 3%
Germany 1 3%
Unknown 35 95%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 7 19%
Researcher 7 19%
Student > Master 5 14%
Student > Bachelor 3 8%
Student > Doctoral Student 2 5%
Other 5 14%
Unknown 8 22%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 9 24%
Agricultural and Biological Sciences 8 22%
Biochemistry, Genetics and Molecular Biology 5 14%
Immunology and Microbiology 2 5%
Psychology 1 3%
Other 2 5%
Unknown 10 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2020.
All research outputs
#4,191,490
of 34,089,221 outputs
Outputs from Leukemia & Lymphoma
#271
of 5,226 outputs
Outputs of similar age
#19,633
of 161,727 outputs
Outputs of similar age from Leukemia & Lymphoma
#5
of 70 outputs
Altmetric has tracked 34,089,221 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,226 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.